Production
Plant
Our production state-of-art plant is one of the largest in Spain with more than 35,000 m2 of facilities equipped with the sector’s most advanced technology and a high capacity, meeting the highest quality standards. It will become the Excellence Centre for controlled-release products of Towa Pharmaceutical (Japan).
million euros invested
in R&D in 2021
Solid: Pellets, Hard gelatin.
Capsules: Tablets. Coated tablets.
Granulates: Powders
Liquid: Solutions and suspensions
120-150
Million units a year
5.600
Million doses/ year (capacity)
0
Packing
lines
0
Processing
teams
0
Laboratory
teams
0
Employees
0m2
Available for future expansion
according to actual building parameters
0m2
Size of
building area
In 2015 we were the first pharmaceutical manufacturer to have the largest photovoltaic installation in Catalonia and the second in Spain, all for our consumption.
During 2022 we plan to expand our investment and enlarge our photovoltaic installation to ensure our sustainable facilities.
View video
Certified management systems
It has systems based on quality assurance and drug safety standards in all processes, from the manufacture of research drugs and commercial drugs to their distribution, in compliance with both Good Manufacturing Practices (EU-GMP and US CFR 21) and Good Distribution Practices (GDP).
ISO 14001
Environment
ISO 45001
Occupational
Health and Safety
Authorization
